$46.35
0.64% yesterday
NYSE, Jun 27, 10:13 pm CET
ISIN
US1101221083
Symbol
BMY
Sector
Industry

Bristol-Myers Squibb Stock price

$46.35
-0.54 1.15% 1M
-11.33 19.64% 6M
-10.21 18.05% YTD
+4.84 11.66% 1Y
-33.63 42.05% 3Y
-11.45 19.81% 5Y
-19.62 29.74% 10Y
+21.45 86.14% 20Y
NYSE, Closing price Fri, Jun 27 2025
-0.30 0.64%
ISIN
US1101221083
Symbol
BMY
Sector
Industry

Key metrics

Basic
Market capitalization
$94.3b
Enterprise Value
$132.3b
Net debt
$37.9b
Cash
$11.8b
Shares outstanding
2.0b
Valuation (TTM | estimate)
P/E
17.42 | 6.79
P/S
1.98 | 2.02
EV/Sales
2.78 | 2.83
EV/FCF
10.11
P/B
5.42
Dividends
DPS
$2.42
Yield 1Y | 5Y
5.22% | 3.49%
Growth 1Y | 5Y
4.76% | 7.57%
Payout 1Y | 3Y
-54.88% | 288.33%
Increased
18 Years
Financials (TTM | estimate)
Revenue
$47.6b | $46.7b
EBITDA
$20.3b | $18.4b
EBIT
$12.9b
Net Income
$5.4b | $13.9b
Free Cash Flow
$13.1b
Growth (TTM | estimate)
Revenue
4.62% | -3.33%
EBITDA
2.90% | -9.66%
EBIT
22.52%
Net Income
188.14% | 255.33%
Free Cash Flow
4.61%
Margin (TTM | estimate)
Gross
74.69%
EBITDA
42.53% | 39.50%
EBIT
27.11%
Net
11.38% | 29.77%
Free Cash Flow
27.47%
Financial Health
Equity Ratio
17.64%
Return on Equity
-54.78%
ROCE
18.89%
ROIC
16.05%
Debt/Equity
2.86
More
EPS
$2.66
FCF per Share
$6.43
Short interest
1.65%
Employees
34.10k
Rev per Employee
$1.42m
Show more

Is Bristol-Myers Squibb a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Bristol-Myers Squibb Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Bristol-Myers Squibb forecast:

10x Buy
31%
20x Hold
63%
2x Sell
6%

Analyst Opinions

32 Analysts have issued a Bristol-Myers Squibb forecast:

Buy
31%
Hold
63%
Sell
6%

Financial data from Bristol-Myers Squibb

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
47,636 47,636
5% 5%
100%
- Direct Costs 12,057 12,057
10% 10%
25%
35,579 35,579
3% 3%
75%
- Selling and Administrative Expenses 7,586 7,586
4% 4%
16%
- Research and Development Expense 9,672 9,672
5% 5%
20%
20,261 20,261
3% 3%
43%
- Depreciation and Amortization 7,345 7,345
20% 20%
15%
EBIT (Operating Income) EBIT 12,916 12,916
23% 23%
27%
Net Profit 5,419 5,419
188% 188%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Bristol-Myers Squibb directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bristol-Myers Squibb Stock News

Neutral
Business Wire
one day ago
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Abecma--U.S. FDA Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy Labels.
Positive
24/7 Wall Street
one day ago
For income investors seeking a timely value stock to buy on the dip, former dividend darling Bristol-Myers Squibb (NYSE:BMY) may fit the bill as one of the top names to watch in the month of July.
Negative
Reuters
4 days ago
Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over a blockbuster multiple myeloma drug sold under the brand name Pomalyst.
More Bristol-Myers Squibb News

Company Profile

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Head office United States
CEO Christopher Boerner
Employees 34,100
Founded 1933
Website www.bms.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today